» Articles » PMID: 88459

Indirect Immunofluorescence Test for Serodiagnosis of Legionnaires Disease: Evidence for Serogroup Diversity of Legionnaires Disease Bacterial Antigens and for Multiple Specificity of Human Antibodies

Overview
Specialty Microbiology
Date 1979 Mar 1
PMID 88459
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence obtained by others who used direct immunofluorescence staining to demonstrate serological differences among strains of Legionnaires disease bacterium prompted this study of parameters influencing the ability of the indirect immunofluorescence test to detect human antibodies to Legionnaires disease bacterium. A total of 25 Legionnaires disease bacterium strains, representing four serogroups, were used as immunofluorescence antigens to test selected human sera. The use of diethyl ether in preparing the antigens was discontinued when it was found that titers against ether-killed group 2 (Togus 1-like) antigens were impossible to determine. Instead, heat-killed suspensions of Legionnaires disease bacterium in 0.5% buffered normal chicken yolk sac were used to show the serogroup diversity of the strains and the serogroup specificity of the antibody response of some, but not all, patients with serological evidence of Legionnaires disease. These studies suggest that multiple antigens should be used in serological tests for Legionnaires disease. Furthermore, the fact that some sera contain antibodies that bind equally well to strains of all four serogroups implies that demonstration of a fourfold increase in titer of paired sera when tested with a single antigen should not be interpreted as evidence of infection with a strain of the same serogroup.

Citing Articles

The mysterious illness that drove them to their knees - Ah, that Legionnaires' disease - A historical reflection of the work in Legionnaires' disease in New Zealand (1978 to mid-1990s) and the 'One Health' paradigm.

Graham F One Health. 2020; 10:100149.

PMID: 33117867 PMC: 7582211. DOI: 10.1016/j.onehlt.2020.100149.


Nosocomial Legionnaires' disease: Clinical and radiographic patterns.

Marrie T, Haldane D, Bezanson G Can J Infect Dis. 2012; 3(5):253-60.

PMID: 22416200 PMC: 3298072. DOI: 10.1155/1992/582736.


Legionella antibodies in a Danish hospital staff with known occupational exposure.

Rudbeck M, Viskum S, Molbak K, Uldum S J Environ Public Health. 2009; 2009:812829.

PMID: 20041020 PMC: 2778453. DOI: 10.1155/2009/812829.


Prevalence of antibodies in response to Legionella species, analysis of a healthy population from Jeollanam-do Province, Korea.

Lee H, Woo M, Ju Y, Baek S, Song H, Choi J J Microbiol. 2008; 46(2):160-4.

PMID: 18545965 DOI: 10.1007/s12275-007-0181-9.


Comparison and evaluation of four commercial kits relative to an in-house immunofluorescence test for detection of antibodies against Legionella pneumophila.

Elverdal P, Jorgensen C, Uldum S Eur J Clin Microbiol Infect Dis. 2007; 27(2):149-52.

PMID: 17992549 DOI: 10.1007/s10096-007-0410-5.


References
1.
McDade J, SHEPARD C, Fraser D, Tsai T, Redus M, Dowdle W . Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med. 1977; 297(22):1197-203. DOI: 10.1056/NEJM197712012972202. View

2.
CHERRY W, Pittman B, Harris P, HEBERT G, Thomason B, Thacker L . Detection of Legionnaires disease bacteria by direct immunofluorescent staining. J Clin Microbiol. 1978; 8(3):329-38. PMC: 275241. DOI: 10.1128/jcm.8.3.329-338.1978. View

3.
McKinney R, Thomason B, Harris P, Thacker L, Lewallen K, WILKINSON H . Recognition of a new serogroup of Legionnaires disease bacterium. J Clin Microbiol. 1979; 9(1):103-7. PMC: 272965. DOI: 10.1128/jcm.9.1.103-107.1979. View

4.
Tsai T, Fraser D . The diagnosis of Legionnaires' disease. Ann Intern Med. 1978; 89(3):413-4. DOI: 10.7326/0003-4819-89-3-413. View

5.
Edelstein P, Meyer R, Finegold S . Isolation of a new serotype of legionnaires' disease bacterium. Lancet. 1978; 2(8101):1172-4. DOI: 10.1016/s0140-6736(78)92154-2. View